CanSinoBIO will continue to drive the innovation and development of vaccines with a global vision by enhancing collaboration with international partners, and contributing more to ... Apr 29
Latest Pharma news updates... Nov 02
Latest pharma news update... Sep 27
Latest Pharma News update... Sep 03
Latest Pharma News Update... Aug 31
This approval follows a priority review designation by the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA) and marks the first ... Jun 23
Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform... Apr 28
Surgery is currently the most common treatment option for the treatment of NMSC which often carry significant cutaneous adverse events, risk of scar, infection, bleeding ... Apr 27
Approval comes after Failure of at Least Two Lines of Prior Systemic Therapy... Feb 22
The product candidate has received multiple IND approvals from both the US FDA and Chinese NMPA... Jan 18
The new Complete Vaccine is also suitable for pregnant women and children... Jan 05
BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
It will be the first clinical trial in China for UME treatment, and also the first one in China to adopt suprachoroidal space (SCS) injection, ... Dec 26
Innovent announces NMPA granted new indication approvals for SULINNO (Adalimumab Injection) for the treatment of pediatric plaque psoriasis and non-infectious uveitis ... Dec 24
The primary endpoint of this trial was to evaluate patients for complete histological clearance of the tumour cells within the treated isSCC lesion... Dec 21
Antengene announces acceptance of IND application in China for ATG-010 (selinexor) in combination with R-GDP (SR-GDP) for the treatment of rrDLBCL in ... Dec 07
The NMPA has approved a dosing label update in China for AstraZeneca’s Lokelma to include patients with hyperkalaemia on chronic haemodialysis.... Nov 25
BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.... Nov 23
Joint venture expands global pharma services capacity for drug development and manufacturing ... Nov 06
This trial will enroll approximately 330 HR+/HER2- mBC patients in Mainland China, Taiwan and South Korea... Nov 02
The survival rate is also relatively higher than other tumour types when having appropriate treatment... Oct 09
The drug trial will start in Korea and China, Cenobamate Tablets are used for partial-onset seizures in adult... Sep 14
Major breakthrough for treatment of Nasopharyngeal Carcinomar ... Sep 11
MicroPort Scientific Corporation completes raising new round of funds for MicroPort CardioFlow Medtech. Corporation.... Apr 17
-Advertisements-
.jpeg)
Monday, November 25, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)